Nicotinamide phosphoribosyltransferase (NAMPT) is a key enzyme for NAD+ production from nicotinamide, and NAMPT expression by a tumor predicts a poor prognosis [9] in colon cancer [10], gastric cancer [11], and lymphoma [12]. This evidence concerns the gene NAMPT and neoplasm.